In the realm of oncology, cancer drug delivery stands as a beacon of hope, revolutionizing treatment strategies and bolstering the efficacy of therapeutics. The essence of this innovative approach lies in its precision, aiming to target cancer cells with unprecedented accuracy while minimizing collateral damage to healthy tissues. Nanoparticles, a key player in this field, serve as potent carriers for anticancer agents. Their minute size allows for enhanced permeability and retention within tumor tissues, ensuring a more focused and efficient drug delivery. Additionally, surface modifications of nanoparticles enable specific interactions with cancer cells, improving the selectivity of treatment.
One of the noteworthy advancements in cancer drug delivery involves the development of smart drug delivery systems. These systems employ stimuli-responsive materials that can release therapeutic payloads in response to specific cues within the tumor microenvironment. This level of sophistication enhances the therapeutic index and reduces adverse effects. Furthermore, personalized medicine has found a robust ally in cancer drug delivery. Tailoring treatment regimens based on individual patient profiles, including genetic and molecular characteristics, has become a reality. This approach not only maximizes treatment efficacy but also minimizes the risk of resistance development. As we delve deeper into the era of precision oncology, cancer drug delivery continues to evolve, promising a future where targeted therapies redefine the landscape of cancer treatment. The synergy of nanotechnology, smart drug delivery, and personalized medicine converges to pave the way for more effective, less toxic, and patient-centric cancer therapeutics.
Cancer represents a major public health and economic burden, being the second leading cause of death worldwide. Despite recent advances in cancer therapy, anti-cancer drug development remains a…
Doxorubicin loaded PLGA nanoparticles were prepared and surface functionalization using trastuzumab, for targeted delivery. Nanoformulations were prepared by double emulsion solvent evaporation…
Participants can earn 1 CPD credit for each hour of attendance.
Oral and poster slots for original Cancer Drug Delivery work, reviewed by the scientific committee.
Meet nanotechnologists, researchers, scientists and engineers from around the world across three days.
In-person and virtual registrations include an electronic copy of the abstract book.
Plenary lectures from leading voices shaping Cancer Drug Delivery research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Cancer Drug Delivery track is a dedicated stream within World Nano 2027 covering the latest research, innovation, and best practice in Cancer Drug Delivery. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Nanotechnology researchers, scientists and engineers, educators and students with an interest in Cancer Drug Delivery are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Yes. World Nano 2027 is a hybrid conference — attend the Cancer Drug Delivery track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.
